EIB PLANS LOAN FOR FERRER R&D
October 1st, 2014THE EUROPEAN Investment Bank (EIB) is planning to lend Euro EUR50 million to Spanish pharmaceutical company Grupo Ferrer Internacional SA, to help it fund a EUR116 million’s worth of scheduled research and development. Studies that would receive financing if the EIB board of directors approves the plan includes medicines to treat central nervous system problems, infections and inflammatory diseases, oncology, diagnostics, plus cardiovascular, respiratory conditions. There will be no environmental impact assessment by bank officials about the loan.
ENDS
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.